Syndax Pharmaceuticals SNDX Free cash flow yield
Free cash flow yield at other companies
Other financials
Where this comes from
Calculated from Syndax Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Syndax Pharmaceuticals's free cash flow yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Syndax Pharmaceuticals's free cash flow yield?
- Syndax Pharmaceuticals (SNDX) reported free cash flow yield of -17.7% in Q4 2025.
- How has Syndax Pharmaceuticals's free cash flow yield changed year-over-year?
- Syndax Pharmaceuticals's free cash flow yield increased by 27.4% year-over-year, from -24.4% to -17.7%.
- What is the long-term trend for Syndax Pharmaceuticals's free cash flow yield?
- Over 5 years (2020 to 2025), Syndax Pharmaceuticals's free cash flow yield has grown at a 24.4% compound annual growth rate (CAGR), from -5.9% to -17.7%.
- What does free cash flow yield mean?
- Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.